Mirae Asset Global Etfs Holdings Ltd. Bio N Tech Se Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Bio N Tech Se stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 18,244 shares of BNTX stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,244
Previous 28,405
35.77%
Holding current value
$2.03 Million
Previous $2.59 Million
24.9%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BNTX
# of Institutions
322Shares Held
41.1MCall Options Held
1.28MPut Options Held
1.43M-
Baillie Gifford & CO8.04MShares$892 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$470 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$444 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$399 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...